-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Jounce Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2016 to Q4 2022.
- Jounce Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending December 31, 2022 was 0.98 USD/shares.
- Jounce Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending December 31, 2022 was -0.99 USD/shares, a 45.6% increase year-over-year.
- Jounce Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -0.99 USD/shares, a 45.6% increase from 2021.
- Jounce Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -1.82 USD/shares, a 46.8% decline from 2020.
- Jounce Therapeutics, Inc. annual Earnings Per Share, Basic for 2020 was -1.24 USD/shares, a 172% decline from 2019.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)